Podcasts about exploramed

Jonathan is joined by Joshua Makower, Director and Co-Founder of the Stanford Byers Center for Biodesign, Stanford University, California, USA. The pair navigate fascinating themes, from Makower's passion for music and his band, Still Trust, to innovative strategies for controlling rising healthcare costs through innovation. Makower offers perspectives on AI in healthcare, and the associated challenges with regulating these new technologies. Use the following timestamps to navigate the topics discussed in this episode: (00:00)-Introduction  (03:05)-A passion for music  (06:11)-From the Massachusetts Institute of Technology (MIT) to medical school  (08:50)-The Biodesign process  (19:37)-Driving technology from mind to marketplace  (23:25)-Doctors engaging with industry  (27:52)-The ExploraMed incubator  (31:07)-Josh's current work  (34:27)-The importance of failure  (36:16)-Perspectives on artificial intelligence in healthcare  (39:05)-Healthcare innovation horizons  (40:37)-Medical technology regulation  (46:00)-Josh's three wishes for the future of healthcare 

“You can be successful as an innovator, even as a physician or any other background you have, as long as you follow the process and really focus on the needs. That's the key.” - Dr Josh Makower, Director and Co-Founder of the Stanford Byers Center for Biodesign.In this episode, Dr Joshua Makower discusses his newest medical device approval "Moximed" and how his multi-disciplinary education of engineering, medicine and business has supported his successful career as an inventor. He goes on to highlight how clinicians and healthcare systems need to embrace innovation to solve some of our biggest challenges. Dr Makower puts forward how lessons working on innovation at Pfizer influenced the Biodesign approach to innovation. Finally, he covers the policy and investment landscape for progressing healthcare innovation.Follow Dr Makower* Twitter/X* LinkedInAbout the guest:Josh Makower, MD is the Boston Scientific Applied Bioengineering Professor of Medicine and of Bioengineering at the Stanford University Schools of Medicine and Engineering, and is the Director and Co-Founder of the Stanford Byers Center for Biodesign, and Founder of Stanford's Biodesign Policy Program.  Josh also serves as a Special Partner on New Enterprise Associate's healthcare team supporting their medtech/healthtech practice.  Lastly, Josh is the Founder and Executive Chairman of ExploraMed, a medical device incubator that has created 10 companies over the past 20 years. Josh currently serves on the board of directors for DOTS Devices, ExploraMed, Allay Therapeutics, Lungpacer, Moximed, Willow Innovations, SetPoint Medical, X9 and Coravin. Josh holds over 300 patents and patent applications for various medical devices in the fields of cardiology, ENT, general surgery, drug delivery, plastic surgery, dermatology, aesthetics, obesity, orthopedics, women's health and urology.Additional resources mentioned in the podcast:* Moximed* Biodesign at Stanford* Book - Biodesign: The Process of Innovating Medical TechnologiesContact Information for the Podcast: If you have any feedback, questions or if you'd like to get in touch, reach out at jono@clinicalchangemakers.comIntro and Out Music Attribution: Music by AudioCoffee from Pixabay This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.clinicalchangemakers.com

“I always go in directions where everyone thinks you can't do something. I'm not a follower. I like to blaze new ground, and I like to take on hard challenges.” When it comes to biodesign and medical device innovation, Josh Makower takes a different approach. Unimpressed by incremental improvements and copycat products, Josh and his team insist on filling gaps in the market by pioneering breakthrough solutions where true need exists — all while considering the full length and breadth of the patient/physician experience and relationship. It's this methodology that has shaped his highly impressive career as a biotech, inventor, founder, entrepreneur, investor, and professor — a career marked by serial success, in which innovation and breakthroughs are the expected norm. Among numerous other titles and credits, he is a Stanford professor of Medicine & Bioengineering, Director and Co-founder of the Stanford Byers Center for Biodesign, and Founder and Exec Chair of medical device incubator ExploraMed. In his hour-long interview by Dr. Grant Stevens, Mr. Makower takes us through a half dozen of his most notable successes, each of which would suffice to define a career. He also delves into the future of biodesign and unpacks how his recent entry into aesthetics could entirely transform the treatment of cellulite. Tune in now to hear it for yourself.

This week we revisit our interview with Caroline (Caro) Van Hove, the President, and CEO of a venture-backed, clinical-stage medical aesthetics company, NC8, an ExploraMed company, and previously held several commercial leadership roles at both start-up and large-cap companies.  She is a global commercial leader with over 20 years of diverse experience in the pharmaceutical, consumer, and medical device industry. Her experience spans North America to Europe, Africa, the Middle East to Asia Pacific, and Latin America.

Josh Makower, MD, rejoins Andrew Cleeland as he shares his experience working at Pfizer, breaking new ground by launching ExploraMed, and coming full circle as co-founder and now director of Stanford Biodesign.   

Anyone who's spent time in the medtech field knows that the name Josh Makower is synonymous with innovation, as he has blazed numerous trails for new technologies and therapies alike. Josh cut his teeth at Pfizer, then went on to become the quintessential entrepreneur, founding eight medtech companies in a variety of clinical specialties including minimally invasive vascular surgery; ear, nose and throat (ENT) issues; and women's health. He created an incubator, ExploraMed, to bring promising technologies to market and has been and still is a general partner at NEA, a global venture capital firm that funds innovation; and is the incoming director of the Stanford Byers Center for Biodesign. In this episode, we discover the personality behind the genius and find out what drives his passion and made him who he is today.   Resources Josh Makower on LinkedIn | Twitter

This week we revisit our conversation with Josh Makower, who was recently selected as the new Director of the Stanford Byers Center for Biodesign. Josh is the Founder and Executive Chairman of ExploraMed, a medical device incubator. He is also a General Partner at NEA and leads the MedTech/Healthtech practice. He also serves at the Stanford University Medical School as an Adjunct Professor of Medicine and is Co-Founder of Stanford's Biodesign Innovation Program. He received an MBA from Columbia University, an MD from the NYU School of Medicine, and a bachelor's degree in Mechanical Engineering from MIT.

This week we interview Caroline (Caro) Van Hove, the President, and CEO of a venture-backed, clinical-stage medical aesthetics company, NC8, an ExploraMed company, and previously held several commercial leadership roles at both start-up and large-cap companies.  She is a global commercial leader with over 20 years of diverse experience in the pharmaceutical, consumer, and medical device industry. Her experience spans North America to Europe, Africa, the Middle East to Asia Pacific, and Latin America.

In this week’s episode, we interview Karen Long, a Managing Director at KCK (Med Tech) Group. KCK focuses on capital investment in commercial and growth-stage medical device companies. Karen has been with KCK since January 2018, when she joined as Executive-in-Residence. Karen serves as Board Director in many KCK portfolio companies as well as Independently. Before KCK, Karen was President and CEO of Nuelle, a women’s consumer health company incubated at ExploraMed, a Silicon Valley medical device incubator. Nuelle was acquired in 2017. Karen has spent over 20 years in medical devices, and diagnostics developing and marketing novel and market-leading products focused on improving the quality of life.  Karen began her career as a Licensed Clinical Social Worker after receiving her undergraduate and graduate degrees from San Diego State University.

This week we interview Josh Makower, a General Partner on NEA's healthcare team leading the MedTech/Healthtech practice. Josh is also the Founder and Executive Chairman of ExploraMed, a medical device incubator that has created eight companies over the past 20 years. Josh serves on the Stanford University Medical School faculty as an Adjunct Professor of Medicine and is Co-Founder of Stanford’s Biodesign Innovation Program. Josh currently serves on the board of directors for a number of Medical Technology companies. Josh holds over 300 patents and patent applications for various medical devices. He received an MBA from Columbia University, an MD from the NYU School of Medicine, and a bachelor's degree in Mechanical Engineering from MIT.

What Investors Are Looking For is the theme of this month’s podcast. It is a panel discussion from the top people and firms who have a track record of successful investments in aesthetics recorded live during this year's Aesthetics Innovation Summit. The panelist include Craig Drill, President of Craig Drill Capital; Adele C. Oliva, Founding Partner at 1315 Capital; Irina Erenburg, CEO & President of Blossom Innovations and Bob Rhatigan, CEO of Merz Americas. It is moderated by AIS Co-Chair Josh Makower, General Partner of NEA Capital and Founder of ExploraMed.Participants:Craig Drill, President - Craig Drill CapitalIrina Erenburg, CEO & President - Blossom InnovationsAdele C. Oliva, Founding Partner - 1315 CapitalBob Rhatigan, CEO - Merz AmericasModerated By:Josh Makower, MD, General Partner - NEA / Executive Chairman - ExploraMed

Josh Makower, General Partner, New Enterprise Associates Josh Makower is a General Partner on NEA's healthcare team leading their medtech/healthtech practice. Josh is also the Founder and Executive Chairman of ExploraMed, a medical device incubator that has created 8 companies over the past 20 years. Notable transactions from the ExploraMed portfolio include NeoTract, acquired by Teleflex in 2017, Nuelle, acquired by Aytu in 2017, Acclarent, acquired by J&J in 2009, EndoMatrix, acquired by C.R. Bard in 1997 and TransVascular, acquired by Medtronic in 2003. On-going ExploraMed/NEA ventures include Moximed, Willow and Exploramed V. In addition to his role at NEA, Josh serves on the faculty of the Stanford University Medical School as a Consulting Professor of Medicine and is Co-Founder of Stanford's Biodesign Innovation Program. Josh currently serves on the board of directors for DOTS Devices, Eargo, ExploraMed, Intrinsic Therapeutics, Moximed, Willow, SetPoint Medical and Coravin. Josh holds over 300 patents and patent applications for various medical devices in the fields of cardiology, ENT, general surgery, drug delivery, obesity, orthopedics, women's health, and urology. He received an MBA from Columbia University, an MD from the NYU School of Medicine, and a bachelor's degree in Mechanical Engineering from MIT.

Bill Facteau joined Earlens Corporation as Chairman, President, and CEO in November of 2013. Most recently, he was the Vice Chairman of ExploraMed, a medical device incubator based on the West Coast and an Entrepreneur in Residence at New Enterprise Associates. Previously, Bill was at Johnson & Johnson from early 2010 through early 2012 as...[read more]Related StoriesWhy Intersect ENT is an Example of Hope for the Medtech IndustryAre Medical Device Models the Key to Building a Lean Medtech Startup?Substantial and Sustainable – 2 Words That Medtech Companies Should Get Used To

For the past two decades, Josh Makower, MD, has sat on the innovator’s side of the table creating innovations and innovators through his work with the Exploramed incu-bator and Stanford Biodesign Program. Now, Makower takes his considerable abilities to New Enterprise Associates, where he’ll invest in medtech companies on behalf of one of the indus-try’s most venerable firms. Hear where he sees opportunity and how Astronaut Steve Austin in-fluenced his career path.

(May 19, 2010) Josh Makower, Founder and CEO of ExploraMed, discusses entrepreneurship and innovation within the medical industry and how to best address the FDA, patenting biotechnologies, etc.

Josh Makower, CEO of ExploraMed, speaks briefly about his experience working in medicine and technology. Dr. Makower also discusses at length the numerous political, financial, and regulatory hurdles against future medical innovation, and calls for audience involvement in the tangled web of healthcare, patents, and insurance reimbursement.

Josh Makower, CEO of ExploraMed, speaks briefly about his experience working in medicine and technology. Dr. Makower also discusses at length the numerous political, financial, and regulatory hurdles against future medical innovation, and calls for audience involvement in the tangled web of healthcare, patents, and insurance reimbursement.

Josh Makower, CEO of ExploraMed, speaks briefly about his experience working in medicine and technology. Dr. Makower also discusses at length the numerous political, financial, and regulatory hurdles against future medical innovation, and calls for audience involvement in the tangled web of healthcare, patents, and insurance reimbursement.